Tebonin Australia - English - Department of Health (Therapeutic Goods Administration)

tebonin

blackmores ltd - ginkgo biloba, quantity: 120 mg (equivalent: ginkgo biloba, qty 6 g; equivalent: ginkgolides, qty 3.7 mg; equivalent: bilobalide, qty 3.5 mg; equivalent: ginkgo flavonglycosides, qty 29.4 mg) - tablet, film coated - excipient ingredients: hypromellose; iron oxide red; purified talc; microcrystalline cellulose; maize starch; titanium dioxide; croscarmellose sodium; lactose monohydrate; macrogol 1500; magnesium stearate; silicon dioxide - antioxidant/reduce free radicals formed in the body ; maintain/support healthy blood circulation ; maintain/support cognitive function/mental function ; maintain/support memory/mental recall

CEREBONIN 120 MG Israel - English - Ministry of Health

cerebonin 120 mg

dr.samuelov importing & marketing ltd, israel - dry extract from ginkgo biloba leaves (35-67:1) - film coated tablets - dry extract from ginkgo biloba leaves (35-67:1) 120 mg - ginkgo biloba - • for the symptomatic treatment of mental losses due to organic brain syndrome within the framework of a general therapeutic concept for dementia syndromes having as major symptoms: deficient memory, disturbances of concentration, depressive mood, dizziness, tinnitus and headache.the primary target group includes patients with demential syndrome in primary degenerative dementia, vascular dementia and mixed forms of both.individual response to the treatment cannot be predicted.note: prior to starting treatment with ginkgo extract, clarification should be obtained as to whether the pathological symptoms encountered are not based on an underlying disease requiring a specific treatment.• vertigo of vascular and involutional origin.• adjuvant treatment in case of tinnitus of vascular and involutional origin.the following note for the patient is included in the instruction leaflet:“frequently occurring dizziness and tinnitus always need to be clarified by a physician. in case of sudden hearing deficit or hearing loss, you should immediately consult a physician.”

Nature’s Own Ginkgo Biloba 2000mg Australia - English - Department of Health (Therapeutic Goods Administration)

nature’s own ginkgo biloba 2000mg

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - ginkgo biloba -

Cenovis Ginkgo Biloba 2000 Australia - English - Department of Health (Therapeutic Goods Administration)

cenovis ginkgo biloba 2000

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - ginkgo biloba -

M-Herbs Ginkgo Biloba Capsule Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

m-herbs ginkgo biloba capsule

multi herbs pharmaceutical (m) sdn bhd - ginkgo biloba dried leaf powder; ginkgo biloba 50:1 extract -

Ginkgo Plus Australia - English - Department of Health (Therapeutic Goods Administration)

ginkgo plus

aussia pharma - ginkgo biloba, quantity: 50 mg; natural fish oil, quantity: 500 mg (equivalent: docosahexaenoic acid, qty 60 mg; equivalent: eicosapentaenoic acid, qty 90 mg); d-alpha-tocopherol, quantity: 6.71 mg; lecithin, quantity: 200 mg - capsule, soft - excipient ingredients: brilliant blue fcf; soya oil; gelatin; purified water; titanium dioxide; allura red ac; hydrogenated vegetable oil; sunset yellow fcf; glycerol; white beeswax - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support general health and wellbeing ; maintain/support healthy blood circulation ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; maintain/support memory/mental recall ; maintain/support brain function ; maintain/support brain health ; maintain/support nervous system function